Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing
Immunotherapy has made great strides in the treatment of lung cancer, but a significant proportion of patients still do not respond to treatment. Therefore, the identification of novel targets is crucial to improving the response to immunotherapy. The tumor microenvironment (TME) is a complex niche...
Main Authors: | Qianqian Xue, Wenbei Peng, Siyu Zhang, Xiaoshan Wei, Linlin Ye, Zihao Wang, Xuan Xiang, Pei Zhang, Qiong Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1148061/full |
Similar Items
-
Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinoma
by: Benjamin Koh, et al.
Published: (2023-12-01) -
Heterogeneity of the tumor immune microenvironment and its clinical relevance
by: Qingzhu Jia, et al.
Published: (2022-04-01) -
The Current Landscape of Immune Checkpoint Blockade in Metastatic Lung Squamous Cell Carcinoma
by: Hong Yuan, et al.
Published: (2021-03-01) -
Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma
by: Zihao Yan, et al.
Published: (2021-12-01) -
Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment
by: Ruiwen Ruan, et al.
Published: (2023-03-01)